BYRN vs. ZVRA
BYRN (Byrna Technologies Inc.) and ZVRA (Zevra Therapeutics Inc.) are both stocks. BYRN operates in Aerospace & Defense (Industrials), while ZVRA operates in Biotechnology (Healthcare). Over the past 10 years, BYRN returned 4.88%/yr vs -14.94%/yr for ZVRA. At a 0.10 correlation, their price movements are largely independent.
Performance
BYRN vs. ZVRA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BYRN achieves a -76.98% return, which is significantly lower than ZVRA's 49.00% return. Over the past 10 years, BYRN has outperformed ZVRA with an annualized return of 4.88%, while ZVRA has yielded a comparatively lower -14.94% annualized return.
BYRN
- 1D
- -1.90%
- 1M
- -40.08%
- 6M
- -77.79%
- YTD
- -76.98%
- 1Y
- -83.17%
- 3Y*
- -1.63%
- 5Y*
- -28.95%
- 10Y*
- 4.88%
ZVRA
- 1D
- -4.23%
- 1M
- 2.93%
- 6M
- 57.24%
- YTD
- 49.00%
- 1Y
- 6.54%
- 3Y*
- 40.34%
- 5Y*
- 0.06%
- 10Y*
- -14.94%
BYRN vs. ZVRA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BYRN Byrna Technologies Inc. | -76.98% | -41.72% | 350.86% | -18.49% | -41.27% | -7.93% | 663.16% | 26.67% | 7.14% | -30.00% |
ZVRA Zevra Therapeutics Inc. | 49.00% | 7.43% | 27.33% | 42.70% | -47.30% | -22.23% | 84.70% | -78.71% | -56.05% | 37.29% |
Correlation
The correlation between BYRN and ZVRA is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.11 |
Correlation (All Time) Calculated using the full available price history since Apr 16, 2015 | 0.10 |
The correlation between BYRN and ZVRA shifts across timeframes, from 0.10 (all time) to 0.21 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
BYRN:
$87.68M
ZVRA:
$789.19M
BYRN:
-$0.16
ZVRA:
$2.15
BYRN:
0.84
ZVRA:
6.31
BYRN:
1.54
ZVRA:
3.91
BYRN:
$108.86M
ZVRA:
$122.29M
BYRN:
$57.17M
ZVRA:
$104.94M
BYRN:
-$3.55M
ZVRA:
$149.15M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BYRN vs. ZVRA — Risk / Return Rank
BYRN
ZVRA
BYRN vs. ZVRA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Byrna Technologies Inc. (BYRN) and Zevra Therapeutics Inc. (ZVRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BYRN | ZVRA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.25 | ||
| Sortino ratioReturn per unit of downside risk | -3.08 | ||
| Omega ratioGain probability vs. loss probability | 0.69 | 1.09 | -0.40 |
| Calmar ratioReturn relative to maximum drawdown | -0.99 | 0.26 | -1.24 |
| Martin ratioReturn relative to average drawdown | -1.65 | 0.45 | -2.10 |
Loading charts...
Drawdowns
BYRN vs. ZVRA - Drawdown Comparison
The maximum BYRN drawdown since its inception was -92.51%, smaller than the maximum ZVRA drawdown of -99.27%. Use the drawdown chart below to compare losses from any high point for BYRN and ZVRA.
Loading charts...
Drawdown Indicators
| BYRN | ZVRA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.51% | -99.27% | +6.76% |
Max Drawdown (1Y)Largest decline over 1 year | -86.01% | -43.47% | -42.54% |
Max Drawdown (3Y)Largest decline over 3 years | -88.70% | -43.47% | -45.23% |
Max Drawdown (5Y)Largest decline over 5 years | -92.51% | -66.94% | -25.57% |
Max Drawdown (10Y)Largest decline over 10 years | -92.51% | -97.85% | +5.34% |
Current DrawdownCurrent decline from peak | -88.70% | -96.47% | +7.77% |
Average DrawdownAverage peak-to-trough decline | -52.50% | -86.47% | +33.97% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 51.63% | 24.89% | +26.74% |
Volatility
BYRN vs. ZVRA - Volatility Comparison
Byrna Technologies Inc. (BYRN) has a higher volatility of 46.46% compared to Zevra Therapeutics Inc. (ZVRA) at 12.44%. This indicates that BYRN's price experiences larger fluctuations and is considered to be riskier than ZVRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BYRN | ZVRA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 46.46% | 12.44% | +34.02% |
Volatility (6M)Calculated over the trailing 6-month period | 74.13% | 40.65% | +33.48% |
Volatility (1Y)Calculated over the trailing 1-year period | 82.31% | 61.17% | +21.14% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 75.22% | 60.33% | +14.89% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 96.16% | 80.82% | +15.34% |
Dividends
BYRN vs. ZVRA - Dividend Comparison
Neither BYRN nor ZVRA has paid dividends to shareholders.
Financials
BYRN vs. ZVRA - Financials Comparison
This section allows you to compare key financial metrics between Byrna Technologies Inc. and Zevra Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
BYRN and ZVRA have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BYRN has higher volatility (46.46%) compared to ZVRA (12.44%). In terms of maximum drawdown, BYRN dropped -92.51% vs ZVRA's -99.27%.
ZVRA currently has the higher Sharpe Ratio (0.18 vs -1.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BYRN and ZVRA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer